Marion J G Bussemakers

Title: Marion J G Bussemakers: Innovator in Prostate Cancer Research

Introduction

Marion J G Bussemakers is a prominent inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of prostate cancer research, holding a total of 4 patents. Her work focuses on the development of diagnostic and therapeutic methods related to prostate-specific antigens.

Latest Patents

Among her latest patents, Bussemakers has developed innovations related to PCA3 genes. The present invention encompasses nucleic acid molecules coding for the PCA3 protein, purified PCA3 proteins and polypeptides, recombinant nucleic acid molecules, and cells containing these recombinant nucleic acid molecules. Additionally, her patents include antibodies specifically binding to PCA3 proteins and polypeptides, hybridomas containing these antibodies, and nucleic acid probes for detecting nucleic acids encoding PCA3 proteins. The inventions also cover methods for detecting these nucleic acids in samples, kits containing nucleic acid probes or antibodies, and bioassays for diagnosing, assessing, or prognosing prostate cancer in mammals. Furthermore, her work includes therapeutic uses and methods for preventing prostate cancer in animals.

Career Highlights

Bussemakers has had a distinguished career, working with esteemed institutions such as Johns Hopkins University and the University Medical Centre at the Catholic University. Her research has significantly advanced the understanding of prostate cancer and its biomarkers.

Collaborations

One of her notable collaborators is William B Isaacs, with whom she has worked closely on various projects related to prostate cancer research.

Conclusion

Marion J G Bussemakers is a key figure in the field of prostate cancer research, with her innovative patents paving the way for improved diagnostic and therapeutic strategies. Her contributions continue to impact the medical community and enhance the understanding of prostate cancer.